Based on its ability to induce a pro-inflammatory immune response, T-bet has been found to regulate factors, including but not limited to STAT-1 expression and IL-23R transcription, which have been linked to pathogenicity in EAE and MS. Here, IL23R is linked to myeloid sarcoma.